filmov
tv
Lead coronavirus vaccine scientist: Here's when we could expect a vaccine
![preview_player](https://i.ytimg.com/vi/a09PhAqw16A/maxresdefault.jpg)
Показать описание
Kizzmekia Corbett, the National Institute of Health's lead scientist for coronavirus vaccine research tells CNN's Anderson Cooper and Dr. Sanjay Gupta that a vaccine for coronavirus could possibly be available to the general public by next spring.
#CNN #News
#CNN #News
Lead coronavirus vaccine scientist: Here's when we could expect a vaccine
We need a vaccine to vanquish COVID-19. Here's how scientists are trying to find it
COVID-19 Vaccines: Science and Safety
Coronavirus vaccine likely by early 2021, here's why
Johnson & Johnson vaccine is a lead candidate for COVID-19
How research into a COVID-19 vaccine could lead to a host of other health innovations | ABC News
WHO Scientist Discusses COVID-19 Vaccines and Variants | LIVE
Spotlight on Science – Coronavirus Vaccines (full version)
Coronavirus: AstraZeneca, University of Oxford says trials show vaccine 'highly effective'
COVID-19 Vaccine Q&A: Temple Health Experts Discuss the Science
Meet the Scientist Behind the Vaccine: A Discussion with Dr. Kizzmekia S. Corbett
COVID-19: Vaccines, Testing, and the Science Behind the Cure
Science Café | Understanding the COVID 19 Vaccine
U.S. scientists begin human trial of coronavirus vaccine
Developing a COVID-19 vaccine: Former FDA chief scientist talks safety, risks, transparency
Doctors Warn New Covid XEC Variant is More Contagious Than Ever
COVID-19 Vaccines: Science, Safety, Efficacy and Distribution: Grand Rounds, Part One
How scientists pulled off a COVID-19 vaccine in 'warp speed' time
Doctor: COVID-19 vaccines 'do lead to a really strong immune response'
Meet the Black female scientist on the forefront of COVID-19 vaccine development
What’s behind coronavirus vaccine skepticism? | COVID-19 Special
Officials on how COVID-19 vaccines may work the future | full video
Long COVID Therapies and The Last Chit Chat
Very high chance of successful coronavirus vaccine, says London trial lead
Комментарии